CCM
EW icon

Conway Capital Management’s Edwards Lifesciences EW Stock Holding History

Conway Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$954K Sell
10,550
-95
-0.9% -$7.96K 0.42% 27
2026
Q1 		$852K Sell
10,645
-250
-2% -$20.6K 0.4% 26
2025
Q4 		$929K Sell
10,895
-250
-2% -$20.5K 0.39% 26
2025
Q3 		$867K Hold
11,145
– – 0.36% 27
2025
Q2 		$872K Hold
11,145
– – 0.39% 27
2025
Q1 		$808K Sell
11,145
-30
-0.3% -$2.15K 0.4% 27
2024
Q4 		$827K Hold
11,175
– – 0.37% 28
2024
Q3 		$737K Sell
11,175
-4,450
-28% -$323K 0.36% 30
2024
Q2 		$1.44M Hold
15,625
– – 0.73% 22
2024
Q1 		$1.49M Sell
15,625
-600
-4% -$50.4K 0.84% 21
2023
Q4 		$1.24M Sell
16,225
-675
-4% -$47K 0.8% 20
2023
Q3 		$1.17M Sell
16,900
-4,250
-20% -$342K 0.86% 22
2023
Q2 		$2M Sell
21,150
-2,425
-10% -$211K 1.4% 15
2023
Q1 		$1.95M Sell
23,575
-900
-4% -$70.7K 1.6% 15
2022
Q4 		$1.83M Sell
24,475
-2,600
-10% -$200K 1.85% 15
2022
Q3 		$2.24M Sell
27,075
-350
-1% -$33.7K 2% 14
2022
Q2 		$2.61M Sell
27,425
-425
-2% -$44K 2.33% 12
2022
Q1 		$3.28M Buy
27,850
+2,650
+11% +$297K 2.1% 13
2021
Q4 		$3.26M Buy
25,200
+2,500
+11% +$292K 1.92% 14
2021
Q3 		$2.57M Sell
22,700
-275
-1% -$31.4K 1.74% 15
2021
Q2 		$2.38M Buy
22,975
+925
+4% +$87.2K 1.63% 15
2021
Q1 		$1.84M Sell
22,050
-200
-0.9% -$16.9K 1.38% 15
2020
Q4 		$2.03M Buy
+22,250
New +$1.85M 1.49% 13

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Conway Capital Management's EW Position: Q2 2026 in Review

Conway Capital Management reduced its Edwards Lifesciences (EW) stake by 0.89% in Q2 2026, selling an estimated $7.96K and leaving 10,550 shares worth $954K. The position accounts for 0.42% of the portfolio, ranked #27.

Conway Capital Management first reported a position in EW in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.28M in Q1 2022. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Conway Capital Management held 10,550 shares of Edwards Lifesciences worth $954K as of Q2 2026.
  • Conway Capital Management sold 95 Edwards Lifesciences shares in Q2 2026, an estimated $7.96K.
  • Edwards Lifesciences made up 0.42% of Conway Capital Management's portfolio in Q2 2026, its #27 holding.
  • Conway Capital Management first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 23 quarters since.
  • Conway Capital Management's Edwards Lifesciences position peaked at $3.28M in Q1 2022.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Conway Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.